Chat with Professor Vande Geest


STBL Receives Translational NIH Award

September 1st, 2023 by Jonathan Vande Geest

The STBL received a developmental grant from the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI). The project, titled “Biocarpet: The Next Generation Endovascular Device for Peripheral Arterial Disease,” began in September 2023 and has received nearly $400,000 in funding. Dr. Vande Geest’s project seeks to address peripheral arterial disease (PAD), Read More

Posted in Uncategorized

EV2 Technologies is Incorporated!

April 1st, 2022 by Jonathan Vande Geest

Prof. Vande Geest and Dr. Behranzade, along with co-founders Dr. John Pacella and Dr. William R. Wagner have co-founded EV2 Technologies to translate the Biocarpet to eventual clinical practice. EV2 will continue to seek non dilutive funding to further develop this technology and prepare for in-vivo assessment.

Posted in Uncategorized

Dr. Vande Geest receives grant on tissue engineering

December 1st, 2021 by Jonathan Vande Geest

The STBL has received funding from the NIH to develop a tissue engineered vascular graft that is fully biodegradable, compliance matched, and maintains that compliance as it is degraded in-vivo. This project involves close collaboration with several other investigators at Pitt and elsewhere. The funded research will involve rodent implantations and culminate with large animal Read More

Posted in Uncategorized

Contact Us